Luo, Y., Azad, A. K., Karanika, S., Basourakos, S. P., Zuo, X., Wang, J., . . . Thompson, T. C. (2018). Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration‐resistant prostate cancer models. Int J Cancer.
Citação norma ChicagoLuo, Yong, et al. "Enzalutamide and CXCR7 Inhibitor Combination Treatment Suppresses Cell Growth and Angiogenic Signaling in Castration‐resistant Prostate Cancer Models." Int J Cancer 2018.
MLA CitationLuo, Yong, et al. "Enzalutamide and CXCR7 Inhibitor Combination Treatment Suppresses Cell Growth and Angiogenic Signaling in Castration‐resistant Prostate Cancer Models." Int J Cancer 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.